Indicated for: cancer
Route of administration: injectable / infusion
Substance: bleomycin sulfate (antineoplastic agent)
ATC: L01DC01 (Antineoplastic and immunomodulating agents | Cytotoxic antibiotics and related substances | Other cytotoxic antibiotics)
This medicine may affect fertility.
Dose adjustment may be needed in liver disease.
Handle with special care.
Effective contraception is required during treatment.
Do not use this medicine while breastfeeding.
Do not use this medicine during pregnancy.
This medicine may affect the liver.
This medicine may have important interactions with other medicines.
This medicine may lower blood cell counts.
This medicine is subject to additional monitoring.
Periodic laboratory tests may be required during treatment.
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Bleomycin sulfate is a medication used in the treatment of certain types of cancer, including Hodgkin's lymphoma, non-Hodgkin's lymphoma, squamous cell carcinoma, and testicular cancer. It belongs to the class of cytotoxic antibiotics and works by damaging the DNA of cancer cells, thereby inhibiting their growth and division.
The medication is usually administered via intravenous, intramuscular, or subcutaneous injection, as directed by a doctor. The dosage and duration of treatment depend on the type of cancer and the patient's overall condition.
Common side effects include fever, chills, nausea, vomiting, and loss of appetite. In rare cases, bleomycin sulfate can cause pulmonary toxicity, manifested as difficulty breathing or persistent cough, which is why patients must be closely monitored.
Bleomycin sulfate is not recommended for pregnant or breastfeeding women, as it may affect fetal development. Patients should inform their doctor about any other medications they are taking to avoid drug interactions.